Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo

Current Biology : CB
G HartmannO Ozcelik

Abstract

Although a number of growth factors bind cell-surface heparan sulphate proteoglycans (HSPGs), the role of this interaction is unclear except for fibroblast growth factor which requires HSPG binding for signalling. Hepatocyte growth factor/scatter factor (HGF/SF) plays important roles in mammalian development and tissue regeneration and acts on target cells through a specific receptor tyrosine kinase encoded by the c-met proto-oncogene. This factor also binds HSPGs with high affinity, but conflicting data have been reported on the role of HSPG binding in HGF/SF signalling. To map the binding sites for HSPG and the Met receptor in HGF/SF, we have engineered a number of HGF/SF mutants in which several clusters of solvent-accessible residues in the hairpin structure of the amino-terminal domain or in kringle 2 have been replaced. Two of the mutants (HP1 and HP2) showed greatly decreased (more than 50-fold) affinity for heparin and HSPGs but retained full mitogenic and motogenic activities on target cells in culture. Furthermore, when compared with wild-type HGF/SF, the HP1 mutant exhibited a delayed clearance from the blood, higher tissue levels and a higher induction of DNA synthesis in normal, adult murine liver. These results es...Continue Reading

References

Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·G HartmannW Birchmeier
Mar 1, 1992·European Journal of Biochemistry·M KomadaN Kitamura
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K M WeidnerY Daikuhara
Apr 1, 1991·The Journal of Cell Biology·U H FrixenW Birchmeier
Nov 1, 1990·The Journal of Cell Biology·K M WeidnerW Birchmeier
Apr 20, 1990·Cell·A Ullrich, J Schlessinger
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·E GherardiR Furlong
Sep 15, 1989·Biochemical and Biophysical Research Communications·K MiyazawaK Takahashi
Feb 1, 1989·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·E M RosenD W Vinter
Jul 14, 1995·The Journal of Biological Chemistry·T F ZioncheckR J Stack
Dec 1, 1994·Protein Science : a Publication of the Protein Society·L E DonateT L Blundell
Aug 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y KatoY Sugiyama
Apr 15, 1994·Structure·R W CarrellM R Wardell
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·K KawaidaT Nakamura
Dec 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K FujiwaraK Kurokawa
May 1, 1996·Nature Structural Biology·G Schreiber, A R Fersht

❮ Previous
Next ❯

Citations

Dec 28, 1999·Journal of Molecular Recognition : JMR·D G Myszka
Apr 20, 2004·International Journal of Cardiology·Rabin GerrahDan Gilon
Nov 14, 2000·The American Journal of Pathology·V J WielengaS T Pals
Jan 9, 1999·Matrix Biology : Journal of the International Society for Matrix Biology·M Lyon, J T Gallagher
Dec 5, 2002·Genes & Development·Véronique Orian-RousseauHelmut Ponta
Sep 6, 2000·British Journal of Clinical Pharmacology·P B SalbachI Walter-Sack
Sep 16, 2004·Molecular and Cellular Biology·Anil KarihalooLloyd G Cantley
May 27, 2014·Nature Chemical Biology·Kyle E LandgrafRobert A Lazarus
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Malgorzata BorowiakCarmen Birchmeier
Oct 23, 2013·Angiogenesis·Xander M R van Wijk, Toin H van Kuppevelt
Feb 11, 2015·Progress in Biophysics and Molecular Biology·Harry JubbDavid B Ascher
Jan 19, 2011·European Journal of Cell Biology·Hartmut H Niemann
Dec 3, 2014·FEBS Letters·Cassie J LiuJennifer R Cochran
May 13, 2009·Molecular Microbiology·C JungV Orian-Rousseau
Aug 1, 2007·Journal of Neurochemistry·Jason A GustinJeffrey Milbrandt
Jul 16, 2015·International Journal of Experimental Pathology·John Gallagher
Feb 23, 2008·Journal of Molecular Biology·Mark YoulesErmanno Gherardi
Jan 10, 2003·Journal of Cellular Biochemistry·Yu-Wen Zhang, George F Vande Woude
Aug 26, 2004·Advances in Cancer Research·Beatrice S Knudsen, Magnus Edlund
Feb 10, 2017·Protein Engineering, Design & Selection : PEDS·Richelle SopkoBlake Pepinsky
Dec 7, 2017·Oncoimmunology·Thivyan ThayaparanJohn Maher
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K KosaiT Nakamura
Apr 24, 2010·Human Molecular Genetics·Leslie Crews, Eliezer Masliah
Dec 20, 2003·Nature Reviews. Molecular Cell Biology·Carmen BirchmeierGeorge F Vande Woude
Jan 4, 2003·Nature Reviews. Molecular Cell Biology·Helmut PontaPeter A Herrlich
Mar 27, 2001·Japanese Journal of Cancer Research : Gann·T AkashiR E Burgeson
Jun 29, 1999·Endocrinology·A CatizoneM Galdieri
Nov 2, 2001·The Journal of Biological Chemistry·Malcolm LyonJohn T Gallagher
Jul 7, 2020·Frontiers in Cell and Developmental Biology·Xinyue HuXing Yu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.